These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8497072)

  • 1. Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120.
    Willey RL; Martin MA
    J Virol; 1993 Jun; 67(6):3639-43. PubMed ID: 8497072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites.
    Pinter A; Honnen WJ; Tilley SA
    J Virol; 1993 Sep; 67(9):5692-7. PubMed ID: 7688827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
    Ivanoff LA; Dubay JW; Morris JF; Roberts SJ; Gutshall L; Sternberg EJ; Hunter E; Matthews TJ; Petteway SR
    Virology; 1992 Apr; 187(2):423-32. PubMed ID: 1546447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.
    Willey RL; Martin MA; Peden KW
    J Virol; 1994 Feb; 68(2):1029-39. PubMed ID: 7904656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability.
    Stamatatos L; Cheng-Mayer C
    J Virol; 1993 Sep; 67(9):5635-9. PubMed ID: 8350416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
    Mathys L; François KO; Quandte M; Braakman I; Balzarini J
    PLoS One; 2014; 9(6):e101181. PubMed ID: 24967714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.
    Moore JP; Willey RL; Lewis GK; Robinson J; Sodroski J
    J Virol; 1994 Nov; 68(11):6836-47. PubMed ID: 7933065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA; Saunders C; Hensel M; Stamatatos L
    J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Freed EO; Martin MA
    J Virol; 1994 Apr; 68(4):2503-12. PubMed ID: 8139032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.
    Xiang SH; Finzi A; Pacheco B; Alexander K; Yuan W; Rizzuto C; Huang CC; Kwong PD; Sodroski J
    J Virol; 2010 Apr; 84(7):3147-61. PubMed ID: 20089638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M; Furman C; Helseth E; Repke H; Sodroski J
    J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.
    Missé D; Cerutti M; Schmidt I; Jansen A; Devauchelle G; Jansen F; Veas F
    J Virol; 1998 Sep; 72(9):7280-8. PubMed ID: 9696823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    Wyatt R; Sullivan N; Thali M; Repke H; Ho D; Robinson J; Posner M; Sodroski J
    J Virol; 1993 Aug; 67(8):4557-65. PubMed ID: 8331723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.